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This study is motivated by understanding and controlling the key physical properties underlying internalisation of nano drug delivery. We
consider the internalisation of specific nanometre size delivery vehicles, comprised of self-assembling amphiphilic block copolymers, called
polymersomes that have the potential to specifically deliver anticancer therapeutics to tumour cells. The possible benefits of targeted
polymersome drug delivery include reduced off-target toxic effects in healthy tissue and increased drug uptake by diseased tissue. Through a
combination of in vitro experimentation and mathematical modelling, we develop a validated model of nanoparticle uptake by cells via the
clathrin-mediated endocytotic pathway, incorporating receptor binding, clustering and recycling. The model predicts how the characteristics
of receptor targeting, and the size and concentration of polymersomes alter uptake by tumour cells. The number of receptors per cell was
identified as being the dominant mechanism accounting for the difference between cell types in polymersome uptake rate.
From the Clinical Editor: This article reports on a validated model developed through a combination of in vitro experimentation and
mathematical modeling of nanoparticle uptake by cells via the clathrin-mediated endocytotic pathway. The model incorporates receptor
binding, clustering, and recycling and predicts how the characteristics of receptor targeting, the size and concentration alter polymersome
uptake by cancer cells.
© 2014 Elsevier Inc. All rights reserved.
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synthetic amphiphilic block copolymers that self-assemble at
neutral pH to form enclosed structures. The membranes of
polymersomes mimic those formed by natural phospholipids1,2
and their synthetic nature means that the physical properties, such
as membrane thickness and fluidity, can be carefully
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pared to naturally occurring lipids or liposomes.5–7 Recently,
polymersomes have been developed for the delivery of
encapsulated molecules which are rapidly internalised by
cells.8,9 These particular polymersomes are comprised of poly-
2-(methacryloyloxy) ethyl phosphorylcholine (PMPC) and poly-
2-(diisopropylamino)ethyl methacrylate (PDPA) block
copolymers.10–12 The PDPA block of the copolymer is pH
sensitive creating amphiphilic copolymers which self-assemble at
pH N6.4 but disassemble when the pH drops below 6.4. Due to
their amphiphilic nature, polymersomes can carry different
therapeutic loads at the same time. They can encapsulate
hydrophilic compounds within their enclosed aqueous core,
hydrophobic compounds within their membranes and/or amphi-
philic compounds aligned at the hydrophilic-hydrophobic
interface.3–5,13 PMPC–PDPA polymersomes have been shown
to be taken up by cells via the endocytotic pathway.8,14 The
dissociation of polymersomes at low pH aids delivery of the
encapsulated materials into the cell cytosol as the endosomal pH
is typically below 6.4. When the polymersomes enter endosomesand experimentation to predict polymersome uptake by oral cancer cells.
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turn leads to an osmotic shock which temporarily ruptures the
endosomal membrane thus releasing the polymersome–delivered
drug into the cytosol, delivering the therapeutic effect.1,14–16
Polymersomes are being developed as a treatment tool for a
range of disease types. Here, we focus on head and neck
squamous cell carcinoma (HNSCC), which includes oral
squamous cell carcinoma (OSCC) and is the sixth most common
cancer worldwide.17 Despite improved patient outcomes in a
range of cancers, the prognostic implications of HNSCC remain
poor. Cisplatin-based chemotherapy and radiotherapy following
surgery have become the standard of care, whilst cisplatin in
combination with 5-Fluorouracil (5-FU) is the mainstay of
treatment for patients with inoperable, recurrent or metastatic
disease. Recently, taxanes such as paclitaxel, in combination
with cisplatin and 5-FU have been shown to improve survival in
patients with locally advanced HNSCC.18 However, high
systemically-delivered doses are required to achieve tumour
killing and these lead to myelosuppression, mucositis and
significant overall toxicity in patients. Therefore, delivery of
anti-cancer drugs directly into the cytosol of tumour cells would
significantly reduce off-target toxicity. In support of this, in a
murine model15 it was shown that a single systemic injection of
polymersomes dual-loaded with the anti-cancer drugs paclitaxel
and doxorubicin caused more tumour cell death, resulted in 50%
smaller tumours and had increased drug accumulation with
decreased toxicity compared to free drugs alone.9 Recently,
polymersomes have been shown to target tumour cells through
their ability to attach ligands or antibodies directed at tumour cell
surface receptors, which may reduce off target toxicity further.19
To advance new forms of drug delivery it is fundamentally
important to understand how the properties of both polymer-
somes and human cells affect cellular uptake, and how to tune
these properties in a treatment-specific way. Here, we develop a
mathematical model for polymersome internalisation validated
against in vitro studies on polymersome delivery to monolayers
of human oral cells and oral tumour cell lines. This model of drug
delivery can be applied to other types of cancer cells and other
polymer-based delivery systems. Studies into the expression of
receptors on the cell surface are combined with the mathematical
model to provide crucial insight into the differences in uptake
rate between different cell types.
Mathematical models of the endocytosis of nanoparticles as
an energy-dependent process dependent on nanoparticle size,20
receptor-clustering,21 dose,22,23 protein corona,24 and receptor-
mediation25,26 have been studied. To the best of our knowledge,
there is no current mathematical model for nanoparticle uptake
present in the literature that is time-dependent, encompasses
translocation of receptors on the cell surface and includes
internalisation rates that depend on receptor-nanoparticle
bond number. Our theoretical model incorporates these
factors, which proved to be important in validating the model
against experimental data. In an extension to the model we
include variability in polymersome size to investigate its effect
on uptake.
Our mathematical model represents the following critical
processes of the cellular uptake of polymersomes: the initial
binding of free polymersomes to cell surface receptors;subsequent binding between bound polymersomes and cell
receptors; internalisation of polymersomes through endocytosis
and the recycling of receptors between the cell interior and
surface. In spite of recent developments in the understanding of
endocytosis27 there are still unknowns; for example, the exact
role of receptors in the formation of an endosome.28,29 We test
hypotheses on how the number of polymersome-receptor bonds
influences uptake by comparing theoretical model output with
experimental data.Methods
Cell culture
This study used the following HNSCC cell lines: Cal27
(American Tissue Culture Collection Manassas, VA, USA),
SCC4 (Health Protection Agency Culture Collections, Salis-
bury, UK) and FaDu (LGC Promochem, Middlesex, UK).
Cal27 cells were routinely cultured in Dulbecco's modified
Eagle's medium (DMEM), FaDu cells in RPMI-1640 both
supplemented with 10% (v/v) fetal calf serum (FCS; BioSera,
East Sussex, UK), 2 mM L-Glutamine, 100 IU/ml penicillin
and 100 mg/ml streptomycin (Sigma, Poole, UK) and SCC4 in
DMEM and Ham's F12 medium in a 1:1 (v/v) ratio
supplemented with 10% (v/v) FCS and 5 mg/ml hydrocorti-
sone. Normal oral keratinocytes (NOK) and fibroblasts (NOF)
were isolated from biopsies obtained from the buccal and
gingival oral mucosa of patients during routine dental
procedures with written, informed consent (ethical approval
number 09/H1308/66) and cultured as previously described.19
Human dermal fibroblasts were isolated from skin grafts
obtained during routine plastic surgery breast reduction and
abdominoplasty operations, with written, informed consent
(ethical approval 06/Q2306/25),30 and cultured in DMEM
supplemented with 10% FCS, 2 mM glutamine, 100 IU/ml
penicillin and 100 mg/ml streptomycin. All cells were
incubated at 37 °C in 5% CO2 and were sub-cultured after
brief treatment with trypsin-EDTA.
Production of rhodamine-labelled polymersomes
PMPC25-PDPA70 copolymer was synthesized by atom
transfer radical polymerization (ATRP) as reported
previously.10,14 To produce rhodamine(rho)-labelled PMPC25-
PDPA70, copolymer was dissolved in a 2:1 chloroform:methanol
solution and rho-PMPC30PDPA60 (10% v/v) added. The co-
polymer film was formed by evaporating the solvent overnight in
a vacuum oven at 50 °C. The film was rehydrated using 2 ml of
100 mM PBS for 7 days under continuous stirring, sonicated for
15 min and then purified by gel permeation chromatography
using a sepharose 4B size exclusion column to extract the
fraction containing vesicles of ~200 nm in diameter as
determined by dynamic light scattering analysis.31
Internalization kinetic analysis using flow cytometry
Full details can be found in the Supplementary Materials.
Briefly, rho-PMPC-PDPA polymersomes (0.1 or 1 mg/ml) were
added to the cell monolayers and incubated at 37 °C for up to
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Biosciences) and the percentage of cells with fluorescence
above control cells (cultured in media alone) and median
fluorescence of whole cell population measured. Details of the
immunoblotting methods and statistical analysis can be found in
the Supplementary Materials.
Mathematical model
The mathematical model is a system of n + 4 ordinary
differential equations, where n is the assumed maximum
number of bonds that can form between the polymersome and
receptors on a cell surface. The equations below describe how
the concentrations of the polymersomes and receptors in
different states vary in time. Here, we assume that the
concentration of cells is constant (although this could easily
be adapted to include cell death, effects of treatment or
toxicity) and B0 denotes the number of free polymersomes
per ml in the solution. The rate of change of B0 over time can
be written as
dB0
dt
¼ −k3anFsB0 þ kdB1; ð1Þ
where Fs is the number of free cell surface receptors per ml,
B1 is the number of polymersomes per ml bound to a cell with
one bond, kd is the dissociation rate (per min), and k3a is the
binding association parameter32 for free polymersomes (ml/
min). The first term on the RHS of equation (1) represents the
binding of a free polymersome to a single receptor. The
second term is the dissociation of polymersomes that are
bound to only one receptor on the cell surface. The rate at
which subsequent bonds form between bound polymersomes
and receptors depends on the average number of surface
receptors per cell given by Fs/M, where M is the number of
cells per ml (assumed constant). The rate equation for B1 is
then given by
dB1
dt
¼ k3anFsB0−kdB1− k2a
M
n−1ð ÞFsB1
þ 2kdB2−kin 1ð ÞB1; ð2Þ
where k2a is the binding association parameter (ml/min) for
polymersomes already bound to the surface of a cell and B2 is
the number of polymersomes per ml bound to a cell with two
bonds. The function kin(i) gives the internalisation rate (per
min) of a polymersome with i bonds (described in more detail
below). The third term on the RHS of equation (2) is the rate
at which polymersomes bound to one receptor subsequently
bind to another receptor on the same cell. The fourth term is
the rate that polymersomes bound by two bonds revert to
being bound by a single bond through the dissociation of one
bond (the dissociation rate is double that of equation (1) as
there are double the number of bonds that can dissociate).
Generalizing this to number of polymersomes per ml with i
bonds, Bi, yields
dBi
dt
¼ k2a
M
n−i þ 1ð ÞFsBi−1−ikdBi− k2a
M
n−ið ÞFsBi
þ i þ 1ð ÞkdBiþ1−kin ið ÞBi; ð3Þfor i = 2,…,n-1. The equation for the number of polymersomes
per ml with the maximum number n bonds, Bn, is given by
dBn
dt
¼ k2a
M
FsBn−1−nkdBn−kin nð ÞBn: ð4Þ
The equations for the rate of change of the number per ml of
free (unbound) surface and internalised receptors, Fs and Fin
respectively, are given by
dFs
dt
¼ −k3anFsB0− k2a
M
Fs
Xn−1
i¼1
n−1ð ÞBi þ kd
Xn
i¼1
iBi þ rFin;
ð5Þ
dFin
dt
¼
Xn
i¼1
ikin ið ÞBi−rFin; ð6Þ
where r is the rate at which internalised receptors are recycled
back to the cell surface. Finally, the equation for the rate of
change of internalised polymersomes Bin is given by
dBin
dt
¼
Xn
i¼1
kin ið ÞBi: ð7Þ
The internalisation rate of a polymersome may depend on the
number of receptors bound to it as receptor clustering can
promote clathrin-coated pit initiation.29 To test this we used two
internalisation functions: the saturating function kin(i) = kin
iγ/(i∗-
+ iγ), where γ and i* are parameters controlling the slope and
the threshold of the function respectively and there is
dependence on bond number i; and the constant function, kin
(i) = kin, which is independent of bond number.
For the most part, the ODE model above is used in the
analysis. However, to validate the model against the experimen-
tal data for the percentage of cells positive for polymersomes as a
function of time (Figure 1, A), the mathematical model is
converted to a stochastic model accounting for individual cells
and individual polymersomes using a Monte Carlo simulation
(Gillespie Algorithm,33 see Supplementary Materials). Variabil-
ity in the cell receptor number and polymersome size is also
included in the stochastic model to investigate how changes in
the polymersome properties (e.g. size) or cell characteristics (e.g.
receptor number) alter the model predictions. We include this
variability in the model by assuming distributions of the relevant
model parameters (see Supplementary Materials).
Model parameters and initial conditions
The experimental concentration of polymersomes in mg/ml is
converted to number per ml for the mathematical model using the
number of copolymers per polymersome and the molecular mass
of a copolymer chain. A 100 nm polymersome is composed of
400 copolymer chains.8 The number average molecular weight
of PMPC25-PDPA70 is 22000 g/mol.
34 Therefore, a polymer-
some concentration of 1 mg/ml is equivalent to 6.81 × 1013
polymersomes/ml. The concentration of cells in the uptake
studies was 5 × 104 cells/ml. The initial concentration of
receptors is determined from fitting the model to the available
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Figure 1. Uptake of polymersomes at two concentrations (0.1 and 1 mg/ml) in FaDu cells and fitted mathematical model output. Percentage of population
positive for polymersomes (A) and fold increase in fluorescence compared to control (B). Model parameters k3a = 1.4 × 10
−19, k2a = 3.9 × 10
−3, kin = 0.612,
n = 40, r = 0.1, kd = 3.75 × 10
−25, γ = 1 and i* = 7.
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typical numbers of receptors per cell32 to ensure physically
meaningful quantities. The other parameters estimated by fitting
are the binding rates k3a and k2a, the maximum number of
receptor-polymersome bonds n and the dissociation rate kd. In
most cases the saturating internalisation function was used with
parameters γ and i* also estimated by fitting. The internalisation
rate kin was taken to be 0.612 per min
21 unless stated otherwise.
The receptor recycling rate was chosen to be 0.1 per min, as
receptors are recycled back to the plasma membrane within
minutes27 and the model predictions turn out not to be sensitive
enough to the recycling rate for it to be fitted to the data. The
method of solution for the model is described in the
Supplementary Materials along with details of the fitting process.
A list of the parameter values is shown in Table 1.Results
Concentration-dependent study
Figure 1, A and B show the experimental data for the uptake
of PMPC-PDPA polymersomes by FaDu cells at 1 and 0.1 mg/
ml, and the corresponding mathematical model output. The
percentage of cells containing a detectable amount of polymer-
somes (Figure 1, A) is significantly (P b 0.05) higher for cells
exposed to 1.0 compared to 0.1 mg/ml rho-labelled polymer-
somes for up to 100 min. The fold increase in the median
fluorescence intensity was also significantly higher when the
cells were exposed to a higher concentration of polymersomes
(Figure 1, B). This study determined the following mathemat-
ical model parameters: number of receptors per FaDu cell;
binding rates k3a and k2a, dissociation rate kd and parameters γ
and i*. Although the fit is reasonable for both doses at later time
points (N10 min), where the average percentage error is 23%
for the high dose and 13% for the low dose, there are large
relative errors (N50%) between the high dose data andsimulation at early time points (≤10 min). Sets of parameters
that produce predictions for the high dose data that match the
early time points had large residual errors at later time points
even when the fitting process was applied to the high dose data
alone (the results shown are for fitting to both doses
simultaneously). The inability of the model to fit to early and
late time points of the high dose data may be due to cellular
adaptive responses which slow the initially rapid uptake, or
there may be another limiting process that is quickly saturated
at high doses. The curves for the simulations of percentage of
cells containing polymersomes are expected to be steeper than
the experimental data because of the lack of variability in the
simulated cells. Note the saturating internalisation function kin
(i) was used, with parameters γ = 1 and i* = 7.
Effect of cell type on polymersome uptake
Figure 2, A and B show the experimental data for polymer-
some uptake for six cell types; two OSCC (Cal27, SCC4), one
oropharyngeal (FaDu) cell line and three primary cell types;
normal human oral keratinocytes (NOK), normal oral fibroblasts
(NOF) and human dermal fibroblasts (HDF). The carcinoma cell
lines show a significantly (P b 0.05) higher percentage of cells
containing polymersomes (Figure 2, A) and display increased
fluorescence demonstrating a higher rate of polymersome up-take
than NOK, NOF or HDF up to 100 min (Figure 2, B). Figure 2, C
and D show the output from model simulations. The different
lines are reproduced by varying receptor number for each cell
line. The similarity between the experimental data and model
output suggests that differences in uptake rates between cell types
can be explained by differences in the numbers of polymersome
binding receptors on the cells. The parameters used were those
determined by the concentration-dependent study and the
saturating internalisation function was used.
Fitting to data from different cell types gives predictions for
the number of receptors per cell. The predicted number will
depend on other parameters, such as binding and internalisation
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Figure 2. Uptake of polymersomes by monolayers of various cell types (A, B) and mathematical model output (C, D) for cells with various numbers of
receptors. Percentage of population positive for polymersomes (A, C) and fold increase in fluorescence compared to control (B, D). Model parameters k3a =
1.4 × 10−19, k2a = 3.9 × 10
−3, kin = 0.612, n = 40, r = 0.1, kd = 3.75 × 10
−25, γ = 1 and i* = 7.
Table 1
Parameters in the mathematical model.
Parameter (unit) Notation Value
Binding association rate free polymersomes to receptors (ml/min) k3a 1.4 × 10
−19
Binding association rate bound polymersomes to receptors (ml/min) k2a 1.9 × 10
−3
Internalisation rate (min-1) kin 0.612
Dissociation rate (min-1) kd 3.7 × 10
−5
Maximum number polymersome:receptor bonds (dimensionless) n 40
Internalisation saturating function (dimensionless) γ, i* 1, 7
Receptor recycling rate (min-1) r 0.1
343I. Sorrell et al / Nanomedicine: Nanotechnology, Biology, and Medicine 10 (2014) 339–348rates, and the form of internalisation function. This is illustrated
in Figure 3 which shows how predictions for receptor number
depend on the internalisation function and the other model
parameters. To make predictions on receptor number the model
is fitted to the data on fold increase in fluorescence (Figure 2, B).
The predictions are for the two cell types (NOF and FaDu) where
the receptor expression has been measured. Figure 3, A and Bshow the percentage difference in the number of receptors per
cell that best fit the NOF and FaDu data for different
combinations of the binding rates k3a and k2a. The figure
includes the ranges of k3a and k2a that can produce predictions
(depending on the other parameters) within 5% of the
experimental data at times greater than 50 min. In Figure 3, A
the internalisation function used was saturating, whereas in
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344 I. Sorrell et al / Nanomedicine: Nanotechnology, Biology, and Medicine 10 (2014) 339–348Figure 3, B the internalisation function was constant. For both
types of internalisation function at least 85% reduction in
receptor number is predicted between FaDu and NOF cells for
nearly all values of k3a and k2a considered.
Of course, differences in the cells, other than receptor
number, may also explain the differences in uptake rate.
However, we do not consider differences in binding rates k3a
and k2a between cell types. These are determined by the diffusion
of polymersomes and interactions between polymersomes and
the cell membrane. We assume that these factors are roughly
similar across cell types; however, the rate of endocytosis may
vary between cell types and influence uptake. Consider the
simplest case that polymersome internalisation is independent of
bond number and the only difference between cell types is the
constant rate of internalisation kin. In this case, to match the
observed differences in uptake the model predicted unrealistic
values for the internalisation rate kin of either NOF or FaDu cells.
Depending on the binding rates k3a and k2a the model predicted
FaDu cells would have to uptake polymersomes at a rate
exceeding plausible rates of endocytosis (considering the
observed lifetime and quantity of clathrin-coated pits29), or
NOF cells would have a rate of endocytosis at least three orders
of magnitude slower than FaDu cells. This suggests that a
difference in the rate of endocytosis between NOF and FaDu
cells is unlikely by itself to account for the difference in their
uptake rates.
To experimentally test whether receptor numbers can explain
differences in uptake between cell types, the receptors involved
in polymersome binding were determined and their expression
by cell type quantified. Recent data suggest that the receptors
likely to be involved in binding polymersomes belong to the
scavenger receptor class B family.18 Immunoblotting shows that
FaDu expresses 5 fold more scavenger receptor class BI/BII than
NOF (Figure 4).Polymersome size variability
Although the model does not include size of the
polymersome explicitly as a parameter, model parameters
implicitly depend on it. For example, larger polymersomes
will diffuse slower but may bind faster to cell surface
receptors. Both effects will alter binding rates. Larger
polymersomes will also have a larger maximum bond number n
and may need more bonds before they are internalised, which is
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345I. Sorrell et al / Nanomedicine: Nanotechnology, Biology, and Medicine 10 (2014) 339–348represented by a larger threshold in the saturating internalisa-
tion function. Controlling the size of polymersomes is part of
the experimental design but the success of this process is
often limited; instead there is typically a Gaussian distribution
of polymersome sizes present in any real sample. To
investigate how this variability affects the uptake of
polymersomes, a distribution of polymersomes can be
included in the stochastic model through a discrete distribu-
tion in one of the relevant parameters. For more details see
the Supplementary Materials.
The distribution in Figure 5, A represents polymersomes
that vary in their internalisation threshold by up to 50% as
larger polymersomes may require more receptor ligand bonds
before they are internalised. Figure 5, A shows the
distribution of free polymersomes added to the cells whilst
Figure 5, B shows the distribution of internalised polymer-
somes. The mean threshold number, which should be
positively correlated to size, is lower for the internalised
polymersomes. Therefore, if these polymersomes carried a
therapeutic load, the amount of drug delivered per cell would
be lower than expected from the number of polymersomes
internalised per cell and the mean amount of drug carried.
However, Figure 5, C shows the uptake of polymersomes
increases as the standard deviation of the size of the free
polymersomes increases. This is because the rate a polymer-
some progresses from initial binding to internalisation will
depend on the reciprocal of the threshold number of bonds.
Polymersomes with a threshold of i* = 5, for example, will
be internalised at roughly twice the rate of the median sized
(i* = 10) polymersomes, whereas polymersomes with a
threshold of i* = 15 will be internalised at roughly 75% of
the rate of the median. In the simulations the increase in the
number of ‘smaller’ polymersomes more than compensates
for the increase in the number of ‘larger’ polymersomes and
results in an increased rate of total uptake.For a constant internalisation function, a distribution of values
of the rate kin is one way to capture variations in internalisation
due to polymersome size. However, varying the standard
deviation of this distribution had almost no effect on the overall
polymersome uptake rate. The distribution of internalised
polymersomes was almost identical to the distribution of free
polymersomes (data not shown).
Larger polymersomes will have more binding sites and may
bind to more receptors faster. This will then decrease the number
of receptors available for binding to other polymersomes. Note
that if the polymersomes were coated in targeting ligands this
would correspond to the number of ligands per polymersome.
The distributions in Figure 6 represent free (Figure 6, A) and
internalised (Figure 6, B) polymersomes that differ in their
number of binding sites n. In this case, the mean of the
distribution of internalised polymersomes is higher than the mean
for the free polymersomes. Figure 6, C shows how the standard
deviation of the polymersome distribution affects uptake rates.
Again, a wider distribution increases the uptake rate.Discussion
This study provides insight into the interaction between
polymersomes and cells in order to aid the design of drug carriers
and treatment regimes. Theoretical models were used to test
assumptions on cellular processes to identify the important factors
for further experimentation that will, in turn, lead to improved
theoretical models. Our theoretical model could be applied to other
nanoparticles and cell types where the uptake mechanism is
clathrin-mediated endocytosis, with suitable experimental data
required to appropriately parameterize the model.
The mathematical model is parameterized against experi-
mental data for two concentrations of polymersomes adminis-
tered to cell monolayers. Importantly, this makes it is possible to
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Figure 6. Distribution of number of binding sites for free polymersomes (A) used in mathematical model resulting in distribution of internalised polymersomes
(B). Uptake of polymersomes (C) for various standard deviations σ of the distribution of the binding sites of the free polymersomes. Model parameters k3a =
1.4 × 10−19, k2a = 3.9 × 10
−3, kin = 0.612, mean n = 15, r = 0.1, kd = 3.75 × 10
−25, γ = 1 and i* = 5.
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administered concentration. The mathematical model was used
to test hypotheses on the different cellular mechanisms involved
in the uptake of the polymersomes. The role of receptors in the
uptake of polymersomes (and other nanoparticles) is not fully
understood.28 We look at two possibilities; that either the rate of
internalisation of a polymersome bound to the surface of the cell
is dependent or independent of the number of receptors it is
bound to. In the model these possibilities are represented by an
internalisation function that was either constant or a saturating
function of the number of receptor-polymersome bonds (other
functions could have been used but any dependency is likely to
be saturating – since the process is receptor mediated). A steep
sloped saturating function approximates a threshold effect,
which represents the number of receptor-polymersome bonds
that are needed before internalisation occurs. We found that the
mathematical model matched the data better when the inter-
nalisation function was saturating rather than constant. This
could be due to the two extra unknown parameters that are fitted;
however, the difference between the two suggests that the
saturating function is more appropriate inferring the rate of
uptake of polymersomes is dependent on the number of bonds
and a threshold effect may be in operation.
Understanding the variation in polymersome uptake across
different cell types is important in the potential use of
polymersomes as an anti-cancer drug delivery system.
Targeted delivery of drugs to cancer cells with delivery
vehicles is highly desired as it could result in less off-target
side effects and higher cancer cell killing efficiency.
Although this study did not use polymersomes with attached
ligands there was still a significantly higher uptake of
polymersomes into cancer cell lines compared to primary
cells. The difference between cell types was investigated
using the mathematical model. Figure 2, C and D show how
altering the receptor number changes the uptake of polymer-somes in line with the observed experimental uptake rates in
the different cell lines, suggesting that receptor number could
be responsible for differences in cellular uptake between
different cell types. Recent data obtained by us and others
suggest that type B scavenger receptors are likely to be
involved in the endocytosis of polymersomes.18 We found
that FaDu expressed significantly more SRB1-B2 than NOF.
We fitted the mathematical model to the FaDu and NOF
receptor data and found that the model predicts FaDu cells
have typically at least 85% more receptors that bind to
polymersomes than NOF. This was broadly in agreement
with the experiments (Figure 4) and indicated that receptor
number has a dominant effect on the differences in uptake
between these two cell types. Scavenger receptors are
expressed in large quantities on macrophages. This corre-
sponds to results from an in vivo murine cancer model where
polymersomes accumulated in macrophages.31
Although the polymersomes are controlled for size, there will
still be a distribution of sizes in any sample of manufactured
polymersomes. This could affect the uptake of polymersomes, so
we assessed the importance of reducing the standard deviation of
the polymersome size distribution. The mathematical model does
not explicitly include polymersome size, but several of the model
parameters will depend implicitly on it.14 Therefore we used the
stochastic model with non-identical polymersomes represented
by parameter distributions. If the internalisation function was
constant, a distribution in the internalisation rate kin did not alter
the uptake of polymersomes and the distributions of free and
internalised polymersomes were identical. If the internalisation
function was saturating, then distributions in the internalisation
threshold and the number of binding sites n both showed an
increased uptake with increasing standard deviation. Also the
mean size of the polymersome internalised differed from the
mean size of the free polymersomes. The distributions used here
should be considered as distributions of polymersomes around
347I. Sorrell et al / Nanomedicine: Nanotechnology, Biology, and Medicine 10 (2014) 339–348200 nm, the size of polymersomes used in this study. Much
smaller or larger polymersomes will be affected by other
physical aspects of endocytosis. For example, a reduction in
gold nanoparticle uptake by HeLa cells below approximately
40 nm and above 50 nm has been reported.35 In our model the
reduced uptake below 40 nm could correspond to the inter-
nalisation rate being a threshold effect where a minimum number
of receptor-polymersome bonds are needed before internalisa-
tion. Nanoparticles smaller than the threshold might not bind to
enough receptors for internalisation to be completed. The
amount of therapeutic load the cells are exposed to will depend
on the size and number of the polymersomes. Given experimen-
tal data on the dependency of polymersome size on uptake,14 the
relationships between size and the model parameters could be
estimated. From this, the model can predict the optimum size of
polymersomes to be used in treatment and how much the
variability in size of a sample of polymersomes will alter the
uptake and encapsulated drug delivery.
In the mathematical model, receptors are recycled to the
surface at a fixed rate. Regulation of receptor recycling and
production probably occurs biologically and may depend on the
number of internalised polymersomes. However, the model
achieves a good fit to the experimental data so regulation of
receptors may not be an important factor for the polymersomes
and receptors considered here. However it is considered to be a
factor in the uptake of other nanoparticles21 and will feature in
our ongoing work on this model.Appendix A. Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.nano.2013.08.013.References
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